Morbi et tellus imperdiet, aliquam nulla sed, dapibus erat. Aenean dapibus sem non purus venenatis vulputate. Donec accumsan eleifend blandit. Nullam auctor ligula

Get In Touch

Quick Email
info.help@gmail.com
  • Home |
  • Xenon phase 3 epilepsy readout ‘blows away’ expectations, stock soars

Xenon phase 3 epilepsy readout ‘blows away’ expectations, stock soars

  • March 9, 2026

Xenon Pharmaceuticals’ anti-seizure candidate has smashed a pivotal trial out of the park, lowering seizure rates by more than 50% for some patients.

Leave A Comment

Fields (*) Mark are Required